Literature DB >> 12924609

Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis.

Katsuya Hiraishi1, Yuji Takeda, Noriyuki Shiobara, Hiromu Shibusawa, Fumie Jimma, Nobuhito Kashiwagi, Abby R Saniabadi, Masakazu Adachi.   

Abstract

Granulocyte and monocyte adsorptive apheresis (GMA) using a column filled with cellulose acetate (CA) beads (carriers) has been associated with a significant clinical efficacy in patients with rheumatoid arthritis and ulcerative colitis. To obtain further understanding on the mechanisms of disease modification by cellulose acetate-carrier-based GMA, in the present study, we investigated the mechanisms of granulocyte and monocyte adhesion to CA beads following exposure of human peripheral blood to the carriers at 37 degrees C for up to 60 min under controlled conditions. Cellulose acetate beads selectively adsorbed granulocytes, monocytes. CD19+ (B cells) and CD56+ (NK cells) lymphocyte subpopulations. The granulocyte and monocyte adsorption was inhibited by heat-inactivated plasma and EDTA, indicating that the adsorption was plasma protein (immunoglobulin, complement) and calcium dependent. Accordingly, granulocyte and monocyte adsorption was markedly enhanced by coating the carriers with IgG. Similarly, C3b was adsorbed onto the CA beads as a marker of complement activation. The results indicated that IgG and active complement fragments mediated leukocyte adhesion to CA beads via the FcgammaR and/or leukocyte complement receptor like CR3. Additionally, CA beads induced loss of expression of TNF receptors on CD16- granulocytes and CD14+ monocytes, but not on CD3+ lymphocytes In conclusion, CA beads might be an appropriate biomaterial for inducing extracorporeal immunomodulation as a treatment for auto-immune diseases which are associated with pathological leukocyte activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12924609     DOI: 10.1046/j.1526-0968.2003.00049.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  30 in total

Review 1.  The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review.

Authors:  H Hanai; Y Takeda; M Eberhardson; R Gruber; A R Saniabadi; O Winqvist; R Lofberg
Journal:  Clin Exp Immunol       Date:  2010-11-16       Impact factor: 4.330

2.  Dramatic response to granulocytapheresis in a Crohn's disease case complicated by hepatitis C virus.

Authors:  Koji Sawada; Kunio Ohnishi; Takeshi Kusaka; Yoshika Matoba; Ken Fukunaga
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

Review 3.  Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease.

Authors:  Yuji Naito; Tomohisa Takagi; Toshikazu Yoshikawa
Journal:  J Gastroenterol       Date:  2007-10-15       Impact factor: 7.527

4.  Down-regulation of interferon-gamma parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease: a 12-month follow-up study.

Authors:  V Muratov; J Lundahl; A K Ulfgren; K Elvin; I Fehrman; N Ahlborg; A Ost; N Hittel; A Saniabadi; R Löfberg
Journal:  Int J Colorectal Dis       Date:  2006-03-15       Impact factor: 2.571

5.  Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis.

Authors:  Emilio Cuadrado; Marta Alonso; Maria-Dolores de Juan; Pilar Echaniz; Juan-Ignacio Arenas
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

6.  Reduction of dendritic cells by granulocyte and monocyte adsorption apheresis in patients with ulcerative colitis.

Authors:  Grit Waitz; Sebastian Petermann; Stefan Liebe; Joerg Emmrich; Wolfgang Ramlow
Journal:  Dig Dis Sci       Date:  2008-02-06       Impact factor: 3.199

Review 7.  Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis.

Authors:  Hiroyuki Hanai
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

8.  Relationship between fecal calprotectin, intestinal inflammation, and peripheral blood neutrophils in patients with active ulcerative colitis.

Authors:  Hiroyuki Hanai; Ken Takeuchi; Takayuki Iida; Nobuhito Kashiwagi; Abby R Saniabadi; Isao Matsushita; Yoshihiko Sato; Naoki Kasuga; Toshihiro Nakamura
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

9.  Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease.

Authors:  Chiara De Cassan; Edoardo Savarino; Piero Marson; Tiziana Tison; Giorgia Hatem; Giacomo Carlo Sturniolo; Renata D'Incà
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

10.  The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease.

Authors:  K Kamikozuru; K Fukunaga; S Hirota; N Hida; Y Ohda; K Yoshida; Y Yokoyama; K Tozawa; K Kawa; M Iimuro; K Nagase; A R Saniabadi; S Nakamura; H Miwa; T Matsumoto
Journal:  Clin Exp Immunol       Date:  2009-03-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.